Beluga Composites Corp. (BGCC/BGCC.PK) Wrap Up:

This record represents the public shell of Biocircuits Corporation. Beluga Composites Corporation ceased operations in May 1998. The company develops immunodiagnostic testing systems. Immunodiagnostic tests or assays are performed on samples of bodily fluids to diagnose a variety of infectious diseases and other conditions, such as endocrine dysfunction, and to conduct therapeutic drug monitoring. Immunodiagnostic tests utilize biological reagents, such as antibodies, and an instrument to detect the presence of a substance of interest such as a virus or hormone. The company's point-of-care immunodiagnostic testing system consists of an instrument and disposable test cartridges that can be operated by a user with no special skills or training. The system enables users to perform tests at many locations, including physicians' offices, ambulatory clinics, and small clinical laboratories. Beluga Composites Corporation was formerly known as Biocircuits Corporation. The company is based in Sunnyvale, California.